Advanced Training Elective in Translational Diagnostics

Advanced Training Elective in Translational Diagnostics Deadline: November 1 The Translational Diagnostics Training Elective offers pathologists-in-training hands-on exposure to how novel histopathology-based diagnostic assays are developed, from ideation to initial validation and development, concentrating on the role pathologists play in this process. This four-week elective takes place in Tucson, Arizona, under the direction of Eric E. Walk, MD, FCAP, chief medical officer of Ventana Medical Systems, and will focus on the process of translating the latest and most promising scientific discoveries and hypotheses in the fields of molecular pathology and oncology to routine diagnostic, prognostic, and companion diagnostic tests for anatomic pathologists around the world. The participant will also be exposed to the various roles pathologists can have in industry through direct interaction with the team of anatomic and molecular pathologists within the Ventana Medical & Scientific Affairs group. The overall goal is to create awareness of how pathologists, working in a product development environment, can significantly impact patient care on a global level through diagnostic innovations and personalized health care solutions. Each elective is customized to the specific interests of the recipient based on a call with Dr. Walk prior to the start of the month. Based on these interests and also project timing and availability, a schedule is created to include exposur...

Source: ScanGrants feed - July 15, 2013 Category: Research Authors: College of American Pathologists Foundation Source Type: funding